NEW: Highlights from GEM 2024...
more
Partner Portal
Newsletters
Use the data
Home page
About
About
Our approach
Using MalariaGEN Data
Where we work
History
Organisms
Parasite
Mosquito
Malaria Vector Genome Observatory
Human
People
Projects
Get involved
Get involved
Apply for a partner study
Data
Data
Latest data releases
Data archive
Studies
Tools & Resources
Tools & Resources
Interpretation Tools
Parasite data tools
Mosquito data tools
Open source software
Amplicon toolkit
P. falciparum protocols
Funding Opportunities
Use cases for NMCP’s
Ethics
Training
Impact
Impact
News
Publications
Videos & Podcasts
Newsletters
Search
Home page
About
About
Our approach
Using MalariaGEN Data
Where we work
History
Organisms
Parasite
Mosquito
Malaria Vector Genome Observatory
Human
People
Projects
Get involved
Get involved
Apply for a partner study
Data
Data
Latest data releases
Data archive
Studies
Tools & Resources
Tools & Resources
Interpretation Tools
Parasite data tools
Mosquito data tools
Open source software
Amplicon toolkit
P. falciparum protocols
Funding Opportunities
Use cases for NMCP’s
Ethics
Training
Impact
Impact
News
Publications
Videos & Podcasts
Newsletters
Search
Partner Portal
Newsletters
Use the data
Home
About
People
Mallika Imwong
Projects
GenRe-Mekong
Partner studies
1262 Randomized trial to assess the safety, tolerability and efficacy of arterolane-piperaquine, arterolane-piperaquine+mefloquine and artemether-lumefantrine
Mallika Imwong
Collaborators
Thailand
